Last updated: February 26, 2024
Sponsor: Tanta University
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Endometrial Biopsy
Clinical Study ID
NCT04867759
uNK in ICSI failure
Ages 20-40 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with IVF/ICSI failures more than 2 times
- Age 20-40 years
Exclusion
Exclusion Criteria:
- prior uterine surgery
- immunological disease
- previous testing to uNK cells
Study Design
Total Participants: 120
Treatment Group(s): 1
Primary Treatment: Endometrial Biopsy
Phase:
Study Start date:
May 01, 2021
Estimated Completion Date:
December 01, 2024
Study Description
Connect with a study center
Adel Elgergawy
Tanta, 3111
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.